Decision uncertainty associated with reliance on surrogate endpoints is a risk to patients and society. HTA agencies may develop more detailed methodological guidance for consistent selection and evaluation of health technologies without definitive final patient-relevant outcome evidence at the time of the assessment.
Surrogate endpoints in health technology assessment: an international review of methodological guidelines
Oriana Ciani;Carlo Federici;
2020
Abstract
Decision uncertainty associated with reliance on surrogate endpoints is a risk to patients and society. HTA agencies may develop more detailed methodological guidance for consistent selection and evaluation of health technologies without definitive final patient-relevant outcome evidence at the time of the assessment.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Grigore2020_Article_SurrogateEndpointsInHealthTech.pdf
accesso aperto
Descrizione: articolo
Tipologia:
Pdf editoriale (Publisher's layout)
Licenza:
Creative commons
Dimensione
892.49 kB
Formato
Adobe PDF
|
892.49 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.